List of insiders holdings for Third Harmonic Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 2024-11-05 18:26:23 | 9,808,190 0 | 9,808,190 | Form 13D |
| 2 | Atlas Venture Fund XI L.P. 10% Owner | 2024-11-05 18:26:23 | 9,808,190 0 | 9,808,190 | Form 13D |
| 3 | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 2024-11-12 18:04:36 | 5,779,071 0 | 5,779,071 | Form 13D |
| 4 | Ho Robert Chief Financial Officer | 2023-03-08 16:58:48 | 598,955 0 | 598,955 | Form 4 |
| 5 | Ray Adrian S. Chief Scientific Officer | 2023-03-08 16:58:02 | 536,871 0 | 536,871 | Form 4 |
| 6 | Holles Natalie C. CEO | 2025-01-17 18:03:43 | 450,000 0 | 450,000 | Form 4 |
| 7 | Conner Edward R. Chief Medical Officer | 2025-01-17 18:08:28 | 148,500 0 | 148,500 | Form 4 |
| 8 | Dinsmore Christopher Chief Scientific Officer | 2025-01-17 18:06:55 | 130,500 0 | 130,500 | Form 4 |
| 9 | Person Julie CHIEF ADMINISTRATIVE OFFICER | 2025-01-17 18:07:46 | 112,500 0 | 112,500 | Form 4 |
| 10 | Dittman Jennifer Chief Operating Officer | 2025-01-17 18:09:33 | 103,500 0 | 103,500 | Form 4 |
| 11 | Dean Dennis Chief Nonclinical Dev. Officer | 2025-01-17 18:04:36 | 103,500 0 | 103,500 | Form 4 |
| 12 | MCDONOUGH GEOFF Director | 2024-03-28 16:10:32 | 60,000 0 | 60,000 | Form 4 |
| 13 | Murphy Christopher M. Chief Financial & Bus. Officer | 2025-03-05 16:01:29 | 30,000 0 | 30,000 | Form 4 |
| 14 | Iwicki Mark T Director | 2024-06-10 16:24:33 | 20,000 0 | 20,000 | Form 4 |
| 15 | Seidel Hans Martin Director | 2024-06-10 16:23:36 | 20,000 0 | 20,000 | Form 4 |
| 16 | Soloway Thomas P Director | 2024-06-10 16:22:32 | 20,000 0 | 20,000 | Form 4 |
| 17 | Gladstone Michael Director 10% Owner | 2024-06-10 16:21:15 | 20,000 0 | 20,000 | Form 4 |
| 18 | Bonita David P Director | 2024-06-10 16:20:03 | 20,000 0 | 20,000 | Form 4 |
| 19 | PEREZ ROBERT J Director | 2023-03-08 17:06:06 | 13,667 0 | 13,667 | Form 4 |
| 20 | Lin Shao-Lee Director | 2022-10-27 16:57:11 | 13,667 0 | 13,667 | Form 4 |
| 21 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2025-04-16 18:49:27 | 0 0 | 0 | Form 13G |